Healthcare
•3734 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3734)
| Company | Market Cap | Price |
|---|---|---|
|
ADAG
Adagene Inc.
Core focus on monoclonal antibody therapeutics (ADG126 and related SAFEbody-based antibodies).
|
$195.03M |
$3.79
-8.57%
|
|
CVRX
CVRx, Inc.
CVRx's Barostim is a neuromodulation device (implantable) that modulates the autonomic nervous system via baroreflex activation for heart failure.
|
$192.91M |
$7.34
-0.20%
|
|
NCSM
NCS Multistage Holdings, Inc.
Tracer diagnostics capabilities and studies are a key service offering for reservoir and well performance analysis.
|
$191.39M |
$74.92
+1.76%
|
|
STXS
Stereotaxis, Inc.
Catheter-based cardiology devices (ablation/catheters) are a core direct product, fitting Cardiology Devices.
|
$189.45M |
$2.00
-0.25%
|
|
PLX
Protalix BioTherapeutics, Inc.
Protalix manufactures recombinant proteins/enzymes (e.g., Elelyso, Elfabrio) using its plant-based ProCellEx system.
|
$186.58M |
$2.31
+0.43%
|
|
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Corbus's pipeline is focused on oncology assets (CRB-701 and CRB-601) representing biotech oncology products.
|
$185.89M |
$10.59
+4.39%
|
|
INGN
Inogen, Inc.
Company manufactures medical devices and respiratory care equipment (POCs, SOCs, Simeox), a core medical devices business.
|
$185.15M |
$6.81
+3.34%
|
|
HRTX
Heron Therapeutics, Inc.
Biochronomer drug-delivery technology is a platform enabling extended-release formulations across Heron's products.
|
$183.36M |
$1.00
+6.91%
|
|
SABS
SAB Biotherapeutics, Inc.
Company focuses on immunology therapeutics using DiversitAb platform to generate fully human polyclonal antibodies.
|
$183.29M |
$3.86
-1.53%
|
|
RNAC
Cartesian Therapeutics, Inc.
Lead platform is an autologous cell therapy using mRNA CAR-T, a direct cell-therapy product line.
|
$183.07M |
$7.03
+10.19%
|
|
NNOX
Nano-X Imaging Ltd.
Directly manufactures diagnostic imaging equipment used for disease detection and monitoring.
|
$182.12M |
$2.85
+4.98%
|
|
AVR
Anteris Technologies Global Corp.
Company directly develops and sells medical devices for the cardiovascular field, specifically the DurAVR transcatheter heart valve and related biomaterial technologies.
|
$178.87M |
$4.91
-1.01%
|
|
MIST
Milestone Pharmaceuticals Inc.
Milestone's lead candidate etripamil is a cardiovascular drug developed for PSVT and AFib-RVR.
|
$178.86M |
$2.11
+0.96%
|
|
SNWV
SANUWAVE Health, Inc.
SANUWAVE directly manufactures and markets medical devices (UltraMIST and related wound-care technology) and biometrics for patient care.
|
$176.75M |
$20.52
+13.87%
|
|
USGO
U.S. GoldMining Inc.
Metallurgical testwork and related lab analyses are conducted to inform processing and PEA.
|
$176.14M |
$13.22
+2.96%
|
|
ACU
Acme United Corporation
SmartCompliance RFID First Aid kits indicate the company produces medical devices & biometrics-enabled safety products.
|
$175.22M |
$46.02
+2.36%
|
|
BDTX
Black Diamond Therapeutics, Inc.
BDTX operates as a biotechnology company focused on oncology therapeutics, i.e., Biotech - Oncology.
|
$174.34M |
$3.07
+5.14%
|
|
PDEX
Pro-Dex, Inc.
Direct product: the company manufactures surgical instruments (autoclavable, battery-powered multi-function handpieces and shavers).
|
$174.19M |
$53.58
+1.86%
|
|
PERF
Perfect Corp.
HD skin diagnostics deployed in aesthetic clinics, representing healthcare-oriented diagnostic software.
|
$174.16M |
$1.73
-0.57%
|
|
LUCD
Lucid Diagnostics Inc.
EsoCheck is a diagnostic collection device used to obtain esophageal cells for testing, aligning with Diagnostic Equipment.
|
$172.10M |
$1.25
-0.40%
|
|
VXRT
Vaxart, Inc.
VXRT directly develops and advances vaccines (norovirus, COVID-19, avian influenza) using its VAAST oral vaccine platform.
|
$170.96M |
$0.75
|
|
ABOS
Acumen Pharmaceuticals, Inc.
Sabirnetug is a recombinant humanized IgG2 monoclonal antibody targeting soluble AßOs.
|
$170.82M |
$2.84
+5.58%
|
|
REPL
Replimune Group, Inc.
Replimune is oncology-focused biotech developing oncolytic immunotherapies.
|
$170.22M |
$2.17
-0.91%
|
|
TLSA
Tiziana Life Sciences Ltd
TLSA's lead product Foralumab is a fully human monoclonal antibody therapeutic, placing the company in Monoclonal Antibody Therapeutics.
|
$169.24M |
$1.25
-7.09%
|
|
TNXP
Tonix Pharmaceuticals Holding Corp.
TNX-102 SL is Tonix's lead oral small-molecule drug for fibromyalgia (cyclobenzaprine HCl sublingual), a direct product the company develops and plans to bring to market.
|
$164.64M |
$13.96
-1.17%
|
|
QTRX
Quanterix Corporation
Quanterix directly manufactures and sells ultra-sensitive diagnostic instruments (Simoa platforms) used for biomarker detection in blood and other samples.
|
$163.49M |
$3.49
+2.65%
|
|
AGEN
Agenus Inc.
Agenus' core focus is oncology with immunotherapy approaches (BOT/BAL) in MSS CRC, supporting Biotech - Oncology.
|
$162.90M |
$4.78
+3.02%
|
|
QIPT
Quipt Home Medical Corp.
Quipt designs/markets medical devices and biometric sensing technology used in home respiratory care and diabetes monitoring (CGMs).
|
$160.70M |
$3.65
-0.14%
|
|
OWLT
Owlet, Inc.
Owlet's devices provide ongoing Patient Monitoring with real-time vital-sign data.
|
$160.24M |
$5.84
+6.57%
|
Showing page 23 of 38 (3734 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
